Suerdem, MecitGünen, HakanAkyıldız, LeventÇilli, AykutÖzlü, TevfikAbadoğlu, ÖznurBayram, HasanCimrin, Arif HikmetGemicioğlu, BilunMısırlıgil, Zeynep2024-01-292024-01-292020Uzunaslan, E. vd. (2020). ''Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study''. International Journal of Chronic Obstuctive Pulmonary Disease, 15, 261-267.1178-2005https://www.dovepress.com/demographic-clinical-and-management-characteristics-of-newly-diagnosed-peer-reviewed-fulltext-article-COPDhttps://hdl.handle.net/11452/39369Purpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naïve asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated . We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4±9.1 years, and 11.9% of the patients were female. 35.1% of the patients were in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines.eninfo:eu-repo/semantics/closedAccessCOPDNewly diagnosedTreatment naiveExacerbationsObstructive pulmonary-diseaseHealt-statusAsthmaComorbiditiesPrevalenceSpirometryCountriesOutcomesAdultAgedComorbidityDisease progressionDrug utilizationFemaleGuideline adherenceHumansMaleMedication adherenceMiddle agedPractice guidelines as topicPractice patternsPhysicians'Prescription drug overuseProspective studiesPulmonary diseaseChronic obstructiveRespiratory system agentsTreatment outcomeTurkeyArticle0005152423000012-s2.0-850794687932612671532103925https://doi.org/10.2147/COPD.S211838Respiratory systemChronic Obstructive Lung Disease; Spirometry; Primary CareBeta adrenergic receptor stimulating agentCorticosteroidLong acting drugMuscarinic receptor blocking agentRespiratory tract agentAdultArticleChronic obstructive lung diseaseCohort analysisComorbidityControlled studyDisease exacerbationDisease severityFemaleFollow upHumanMajor clinical studyMaleMedication complianceMiddle agedObservational studyPatient attendancePatient compliancePrescriptionProspective studyTurkey (republic)AgedChronic obstructive lung diseaseClinical practiceClinical trialDrug utilizationMedication overuseMulticenter studyPathophysiologyPractice guidelineProtocol complianceTreatment outcomeTurkey (bird)